Ollie’s Bargain Outlet Earnings: OLLI Stock Down on Weak 2019 Guidance

Ollie’s Bargain Outlet (NASDAQ:OLLI) posted its latest quarterly figures late Tuesday, bringing in earnings that topped the mark, while revenue and guidance disappointed.

The Harrisburg, Penn.-based retail chain posted net income of $49.9 million, or 76 cents per share for its fourth quarter of fiscal 2018. On an adjusted basis after considering tax and debt purposes, the business amassed earnings of 71 cents per share, roughly 20 cents per share above the year-ago period.

Wall Street called for Ollie’s to rake in adjusted earnings of 70 cents per share. The business added that its sales for its last three months of fiscal 2018 tallied up to $393.9 million, up from $356.7 million during the same period in 2017. Analysts predicted the company’s sales would come in at $398 million.

For its fiscal 2019, the retail company now sees its adjusted earnings as being somewhere in the range of $2.10 a share to $2.15 per share, above the $1.85 per share in adjusted earnings it brought in for its fiscal 2018. The range’s midpoint of $2.125 per share is below the Wall Street adjusted earnings guidance for Ollie’s fiscal 2019 of $2.15 per share.

The business also predicts revenue of $1.44 billion to $1.45 billion for its 2019, ahead of the $1.24 billion of its fiscal 2018. Analysts see this figure at $1.446 billion, ahead of the company’s own guidance.

OLLI stock is falling about 3.6% after hours on Tuesday following a 1% gain during regular trading Tuesday for Ollie’s.

Compare Brokers

Buy Larsen and Toubro; target of Rs 1655: Sharekhan

Sharekhan's research report on Larsen and Toubro

L&T has a strong investment & cash balance apart from strong operating cash flow generation. It would therefore be able to execute the transaction without stretching its balance sheet. Deployment of free cash in a business with relatively higher return ratios would not adversely impact L&T's earnings estimates and return ratios on a consolidated basis.

Outlook

Notwithstanding the near term challenges due to unwarranted resistance by the management of Mindtree, we see the acquisition of stake in Mindtree as a positive move by L&T and retain our Buy rating on the stock with target price of Rs1655.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Mar 20, 2019 04:19 pm

D-Street Buzz: Zee Ent drags Nifty Media 2%, energy stocks also slip; Infosys gains

The Indian benchmark indices are trading on a flat to negative note with Nifty shedding 10 points, trading at 11,521 whereas Sensex is down 22 points, trading at 38,341.

At 0934 hours, Nifty Media is the underperforming sector, down over 2 percent dragged by Zee Entertainment that shed 4 percent followed by Dish TV, UFO Moviez, INOX Leisure and Sun TV Network.

Oil & gas stocks are also trading in the red with losses from BPCL, HPCL, Indian Oil Corporation and Reliance Industries.

From the PSU banking space, the top losers are State Bank of India, Punjab National Bank, Oriental Bank of Commerce, Indian Bank, Canara Bank and Bank of India.

related news Viaan Industries locked at upper circuit as co decides to acquire stake in Avalance Technology Datamatics Global Services rises 3% on acquiring additional stake in subsidiary Jet Airways plummets 5% after docking of 6 additional aircraft

Nifty PSE is also down over a percent dragged by NMDC, NHPC, Oil India, PFC and NTPC.

However, Nifty Realty is the outperforming sector led by Indiabulls Real Estate, DLF, Godrej Properties, Prestige Estates and Oberoi Realty.

From the IT space, the top gainers are Infosys that added close to 2 percent followed by Tata Elxsi, Tech Mahindra and Wipro.

The top Nifty gainers included Indiabulls Housing Finance, Infosys, Wipro, Hindalco Industries and Vedanta while the top losers included Zee Entertainment, IOC, HPCL, BPCL, and ONGC.

The most active stocks were Jubilant Life Sciences that shed 5 percent followed by Infosys, Axis Bank, Indiabulls Housing and Reliance Industries.

Axis Bank, Refex Industries, Titan Company and Alok Industries have hit 52-week high on NSE.

The breadth of the market favoured the declines with 717 stocks advancing and 842 declining while 507 remained unchanged. On the BSE, 725 stocks advanced, 736 declined and 83 remained unchanged.

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd. First Published on Mar 20, 2019 10:10 am

Here are the biggest analyst calls of the day: Facebook, Dollar General

Here are the biggest calls on Wall Street on Monday:

Needham downgrading Facebook to 'hold' from 'buy'

"FB is within 2% of our price target and we are downgrading our rating to Hold (from Buy) as we worry about: a) the negative financial impact of FB's strategic pivot toward privacy and encrypted messages; b) growing risks of regulation; and c) horrific images uploaded to FB (like the recent New Zealand events) that are technologically difficult to block at the 100% level and which hurt FB's brand... Together, we believe these risks are causing a Negative Network Effect, as evidenced by senior management departures... Network Effects act as flywheel accelerator for both value creation and value destruction.... We make no changes to our estimates, which are below Wall Street consensus estimates..."

Read more about this here.

Bank of America lowering price target on Facebook to $187 from $205

"While we continue to think estimates have been de-risked in 2019, the revenue impact of a more privacy centric platform could raise questions on three-year growth... Highest usage growth areas for FB were noted as private messaging, ephemeral stories, and small groups, which have lower current monetization and raises the revenue risk from a potential ongoing usage transition... While FB still has big opportunities to improve the monetization of stories and messaging, the question is if usage will deteriorate on core news feed... We are staying constructive as we think news feed usage has stabilized after a summer trough, but would turn more cautious if usage data deteriorates...We are maintaining our estimates and lowering our PO to $187 based on a lower multiple of 20x 2020e GAAP EPS plus $13/share in cash to reflect monetization uncertainty (prior 24x)...Based on a more limited upside view for FB (stock up 27% YTD vs S&P up 13%) ,we are shifting to Google as top near -term FANG idea given potential for a valuation sentiment uptick on assets including Waymo and Cloud (April conference)..."

Barclays upgrading Dollar General to 'overweight' from 'equal weight'

"DG is doing what all best-in-class retailers do – investing from a position of strength to widen its competitive edge, even if it means NT guidance disappoints. It is critical to invest when times are good to be better positioned should the tide turn. We've seen this time and time again from other best-in-class retailers – in our universe, we would include COST and WMT; in other sectors, HD, ORLY, and MCD. Accordingly, while DG's investments led to disappointing FY19 guidance, DG should (and will) capitalize on the opportunity to widen its competitive moat as Fresh/Fast Track investments will lead to: 1) greater frequency of visits, 2) a more robust/efficient supply chain, 3) lower costs-to-serve, and 4) labor productivity gains. FY19 is an investment year – we acknowledge that – but DG is positioning itself to gain share LT..."

Wells Fargo upgrading Johnson Controls to 'outperform' from 'market perform'

"The gist of our thesis is the timing is now better for the story to play out – Expectations and sentiment are pretty low, even as fundamentals are picking up (backlog acceleration, peaking investment/cost headwinds, higher FCF yield etc.,)... Post the 06/19 Power sale close, JCI should be a more focused pure play buildings automation company and much of the noise and distraction should be behind them.... In our view the embedded earning for F'19/F'20 is $2.45/$2.80 (incld. Power sale proceeds deployed), indicating a PE of ~17x/15x (not far from where it is trading now), on our street high $42 price target..."

Wells Fargo downgrading Ingersoll-Rand to 'market perform' from 'outperform'

"At $106 (as of 03/15 close), the stock appears to be priced for superb execution in F'19, in our view... Our bull bear scenario indicates risk reward is skewed to the downside... We acknowledge our downgrade is valuation driven... The mgmt has remarkably steered through price-cost headwinds in 2018 and that has set performance expectations higher..Key points..1) Expectations are at cycle high - 70% of the street has a buy on IR – highest since 2012.. Buyside sentiment is trending at the high end of historical range as well... 2) C-HVAC growth expectations are above trend... This is fine given institutional acceleration outlooks but not much head room left, in our view... Climate revenue growth for 2019 is 6% vs normalized 5% growth averaged between 2013-2017. 2018 growth was a record 9% and as such is a tough comp... 3) Any missteps likely costly for IR. Given high expectations, any shortfall in resi would be considered share loss to the re-emerging peer LII.... 4) Industrial order growth moderated in 2018 vs expectations for a pickup in momentum... The trend could continue near term. ..5) NTM FCF yield is slightly below last 5 yr trend (5.6% now vs 6.5% average the last few years. NTM FCF yield is also lower vs peers like JCI (6% IR vs 8% JCI)..."

PiperJaffray raising price target on Chipotle to $725 from $661

"Chipotle remains our top recovery investment recommendation and we have a high degree of conviction that current strategic initiatives can continue to generate improving fundamentals... As the company progresses through its recovery process we believe the conversation (from a stock perspective) eventually shifts to one that focuses on identifying incremental strategies to maximize shareholder value... In that vein, we offer an initial examination of the potential behind transforming Chipotle's international store base (currently only ~14 company-owned units across the UK, France, and Germany) into a growing franchise business... Although hypothetical, such a future transformation could help to unlock incremental profitability (driving an estimated $2 to $5 in earnings power), drive upside to global growth, and potentially set up CMG shares for some measure of multiple expansion as the company becomes incrementally asset-light, over time... We reiterate our Overweight rating and are increasing our price target to $725 on CMG shares..."

Goldman Sachs upgrading Okta to 'buy' from 'neutral'

"Okta's strong results since its April 2017 IPO continue to demonstrate the growing role that identity is playing in the wider enterprise IT ecosystem, given its crucial positioning at the intersection of heightened concerns around security, increasingly complex multi-cloud environments, and the digital revolution of businesses in every sector... As digital transformations continue to drive discussion at the C-level, we believe that identity will play an important role in establishing more robust internal processes around access and authentication across increasingly complex enterprise IT topologies, while serving as an important tool in driving more secure experiences for users outside the organization...
In our view, Okta remains the leader in Identity and Access Management within the enterprise, and continues to benefit from its role as an independent, third party management platform for identity and user authentication that works across cloud environments to provide a unified platform to manage access to applications, devices, and third-party application programming interfaces..."

Citi downgrading PVH to 'neutral' from 'buy'

"We are assuming coverage with a Neutral rating (vs previous rating of Buy) and a $120 TP (vs previous TP of $140). While the company has two brands with good global growth potential in Tommy Hilfiger and Calvin Klein, PVH overall is still heavily dependent on the North America wholesale and outlet channels (we estimate these channels combined represent ~50% of sales)... Despite management typically beating guidance in the past, we are concerned that exposure to wholesale/outlet channels will weigh on sales and profits in the coming years, limiting upside..."

Credit Suisse downgrading Quest Diagnostics to 'neutral' from 'outperform'

"Despite multiple unexpected headwinds affecting DGX's 2018, including greater denials and higher-than-expected patient concessions, among other factors, we are optimistic that long-term growth drivers are intact, including greater in-network access, continuing innovation, consumer-centric initiatives, and capital deployment, where reimbursement pressures and recent payer contract shifts will likely spur industry consolidation... These drivers should support +3-5% top-line growth (+1-3% organic) and +4-6% earnings growth long term, dynamics that we view as adequately reflected in the consensus and our expectations, limiting more meaningful upside near term..."

Why Marijuana REITs Are One of the Best Investments Today

Legal marijuana is on the brink of explosive growth. But there are two key hurdles to overcome… and marijuana REITs like Innovative Industrial Properties (NYSE:IIPR) are solving them both.

For growers, it’s not easy to produce high-grade marijuana. Nor is it cheap — and getting that funding is tricky. Until the U.S. government removes marijuana from its list of Schedule I drugs — the ones considered most dangerous, like heroin — most banks want no part of it. (No matter how bright the future looks.)

For investors, the options have been limited, as that Schedule I label prohibits most U.S. companies from listing on the NYSE or NASDAQ.

Notice I said “most.”

IIPR stock is one of the few. Why can it list on those major stock exchanges? Because it never actually touches the plant. This is one of the smartest ways to invest in the exploding marijuana industry while it is still technically illegal federally.

Like all marijuana REITs, Innovative Industrial Properties simply plays landlord to the growers. Here’s how it works: IIPR buys freestanding properties from medical marijuana growers licensed by their respective states. It then leases the properties back to the growers. This gives those growers an infusion of capital to expand their operations and increase production. In return, the REIT receives regular rent payments under a long-term lease.

Pretty slick, huh? Wall Street is certainly taking notice:

Institutional investors now hold 59% of IIPR stock. Big players like Vanguard, Blackrock, and Wellington were largely the ones to cash in when shares hit a new 52-week high on the company’s March earnings report.

But marijuana REITs are also popular among investors like you and me — because of their unique business model, as well as their dividends.

Take a look at Innovative Industrial Properties’ earnings and you’ll see its rental income is growing exponentially. Then, because of the REIT structure, at least 90% of that gets passed along to shareholders. Innovative Industrial Properties paid a $0.35 dividend in Q4 — 40% higher than the previous year — and it’s already announced another dividend hike in Q1, to $0.45. That makes for a nice forward yield of over 2%. (This is even after the price of the stock nearly doubled since December.)

IIPR is a great stock, and now everybody is finding that out.

But I like to invest way BEFORE everyone jumps on board. Getting in before the crowd is how you make the big money. And that stock is up over 160% since I recommended it to my Investment Opportunities readers last August.

Back in college, I bought a brand-new apparel stock called True Religion for $0.20 — then it popped up above $20.

That’s actually what set me on my journey to New York City… my career with Charles Schwab, then my own firm, Penn Financial Group… and nowadays my newsletters, including Investment Opportunities.

I got people into Intuitive Surgical (NASDAQ:ISRG) at $10. Now it’s over $550. We saw GrubHub (NYSE:GRUB) go from $35 to $140.

I like to wait a couple of months after the IPO before investing, to avoid early volatility. That’s what I advised for Facebook (NASDAQ:FB), which did in fact make an early stumble before it went into the stratosphere. (I’m still waiting for Twitter (NYSE:TWTR) to “show us the money.”)

And now, I’ve got my eye on a company called Treehouse.

Compare Brokers
The Next IIPR?

Treehouse is one of the marijuana REITs I think you should put on your radar. It’s an up-and-comer, and this one focuses on retail, in addition to cultivation facilities.

On Monday, Treehouse announced that it had raised $45.5 million in a private deal. (And that was from a “federally-insured commercial bank” — a great example of how marijuana REITs can break that funding barrier.) That’s after the REIT raised $133 million in its spinoff from MedMen Enterprises (OTCMKTS:MMNFF) in January.

Treehouse is looking to expand its lineup of cannabis retail and industrial facilities…

… and I also think it’s headed toward an IPO.

That’s right. Treehouse is still privately held, but maybe not for long.

Large amounts of private fundraising tend to indicate a company is building toward its “exit” in the form of a public offering. One study from PitchBook found that venture capital-backed companies were raising an average of $108 million before an IPO.

If the rumors start flying and you hear about Treehouse on TV, well… you heard it here first. I’ll definitely be keeping an eye on this REIT — and so should you.

Now, don’t get me wrong:

If Treehouse goes public, it wouldn’t necessarily be an automatic buy. There’s some homework to do first: make sure the fundamentals back up the hype. And the timing has to be right.

That’s all part of my Cannabis Cash Calendar system, which I designed specifically for marijuana IPOs. The early results are impressive, if I do say so myself, including an 80% gainer in less than four months.

I already have the date circled for my next recommendation — just two weeks away, on April 4.

You can get exclusive access to it as soon as it’s released to my Investment Opportunities readers. Click here to learn more about this opportunity and how to get on the list to be notified.

Even if you don’t know a thing about the marijuana markets… even if you’ve never bought a stock before. You could take just a small stake, and potentially multiply that over the next 12 months. Click here for more on this incredible trend.

Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world’s biggest, most revolutionary trends BEFORE anyone else. The power of being “first” gave Matt’s readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you’re interested in making triple-digit gains from the world’s biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments s

Hanmi Financial Corp (HAFC) Expected to Announce Earnings of $0.48 Per Share

Analysts forecast that Hanmi Financial Corp (NASDAQ:HAFC) will report $0.48 earnings per share for the current quarter, according to Zacks. Four analysts have issued estimates for Hanmi Financial’s earnings. The highest EPS estimate is $0.49 and the lowest is $0.46. Hanmi Financial posted earnings per share of $0.46 in the same quarter last year, which suggests a positive year-over-year growth rate of 4.3%. The business is expected to issue its next quarterly earnings report on Tuesday, April 23rd.

On average, analysts expect that Hanmi Financial will report full year earnings of $2.14 per share for the current financial year, with EPS estimates ranging from $2.00 to $2.25. For the next year, analysts expect that the firm will post earnings of $2.33 per share, with EPS estimates ranging from $2.10 to $2.47. Zacks’ EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Hanmi Financial.

Get Hanmi Financial alerts:

Hanmi Financial (NASDAQ:HAFC) last posted its earnings results on Tuesday, January 15th. The bank reported $0.46 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.51 by ($0.05). Hanmi Financial had a return on equity of 10.74% and a net margin of 22.35%. The company had revenue of $51.95 million during the quarter, compared to analysts’ expectations of $51.95 million. During the same period in the prior year, the business posted $0.48 earnings per share.

HAFC has been the subject of a number of recent research reports. BidaskClub raised shares of Hanmi Financial from a “hold” rating to a “buy” rating in a research report on Friday, January 25th. ValuEngine cut shares of Hanmi Financial from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 7th. TheStreet raised shares of Hanmi Financial from a “c+” rating to a “b-” rating in a research report on Wednesday, February 20th. Zacks Investment Research cut shares of Hanmi Financial from a “hold” rating to a “sell” rating in a research report on Friday, January 18th. Finally, Raymond James cut shares of Hanmi Financial from an “outperform” rating to a “market perform” rating in a research report on Monday, January 7th. Three research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. Hanmi Financial currently has an average rating of “Hold” and a consensus price target of $27.33.

Shares of NASDAQ:HAFC traded down $0.06 on Thursday, hitting $21.51. The company had a trading volume of 126,600 shares, compared to its average volume of 201,568. Hanmi Financial has a 1 year low of $17.56 and a 1 year high of $32.10. The company has a current ratio of 1.00, a quick ratio of 0.99 and a debt-to-equity ratio of 0.31. The stock has a market cap of $663.60 million, a price-to-earnings ratio of 11.32, a P/E/G ratio of 1.26 and a beta of 1.00.

Hanmi Financial declared that its Board of Directors has initiated a share repurchase plan on Thursday, January 24th that allows the company to buyback 1,500,000 shares. This buyback authorization allows the bank to repurchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 28th. Investors of record on Wednesday, January 30th were given a dividend of $0.24 per share. The ex-dividend date was Tuesday, January 29th. This represents a $0.96 dividend on an annualized basis and a yield of 4.46%. Hanmi Financial’s dividend payout ratio (DPR) is currently 50.53%.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Flinton Capital Management LLC lifted its position in Hanmi Financial by 30.3% during the 4th quarter. Flinton Capital Management LLC now owns 5,544 shares of the bank’s stock valued at $109,000 after acquiring an additional 1,288 shares during the period. Neuburgh Advisers LLC lifted its position in Hanmi Financial by 30.3% during the 4th quarter. Neuburgh Advisers LLC now owns 6,732 shares of the bank’s stock valued at $133,000 after acquiring an additional 1,564 shares during the period. Metropolitan Life Insurance Co. NY lifted its position in Hanmi Financial by 356.5% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 10,604 shares of the bank’s stock valued at $209,000 after acquiring an additional 8,281 shares during the period. Oregon Public Employees Retirement Fund purchased a new position in Hanmi Financial during the 4th quarter valued at about $238,000. Finally, Magnus Financial Group LLC purchased a new position in Hanmi Financial in the fourth quarter worth about $280,000. 88.02% of the stock is owned by institutional investors.

Hanmi Financial Company Profile

Hanmi Financial Corporation operates as the holding company for Hanmi Bank that provides business banking products and services in the United States. The company offers various deposit products, including noninterest-bearing checking accounts, interest-bearing checking and savings accounts, negotiable order of withdrawal accounts, money market accounts, and certificates of deposit.

Read More: What does relative strength index mean?

Get a free copy of the Zacks research report on Hanmi Financial (HAFC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Here's how to navigate the booming business of college advisors

Helping kids get into college is a big business — and it's growing fast.

The industry gained some unwelcome notoriety early this week when dozens of people — including actresses Felicity Huffman and Lori Loughlin — were arrested in an admissions bribery scheme.

The person behind it was William "Rick" Singer, founder of the Edge College & Career Network. He pleaded guilty to a number of charges, including racketeering, for masterminding the scheme, which included bribing college athletic coaches and having other people take admissions tests for the children of those who hired him.

Members of the profession swiftly condemned Singer's actions and pointed out that the charges exemplified the concern parents feel about getting their children into the right college.

"We know anxiety is off the charts. Part of the reason anxiety is off the charts is the decision-making in colleges has become so opaque," said Mark Sklarow, CEO of the Independent Educational Consultants Association. "We see that parents are willing to do just about anything."

His organization, a nonprofit that represents independent educational consultants, estimates there are about 8,000 people in the profession full-time, as well as thousands more who "dabble" in it.

The IECA has about 2,000 members — double the number from five years ago — who are required to abide by a code of conduct.

What you get for your money

The purpose of a college consultant is to help parents and their children navigate the application process, prepare for entrance exams and choose the right college — and it can cost a lot of money. The average hourly fee in 2018 was $200, according to the IECA. Comprehensive package costs range from $850 to $10,000.

Chris Rim, founder and chairman of Command Education, told CNBC on Friday he creates a yearlong road map for students that includes their objectives and what they need to do to stay on track. His fees start at $950 an hour.

"Because admission rates are so low, you can't just have ... straight As, perfect or near-perfect SAT or ACT scores. You are going to need something that makes you stand out," he said on "Power Lunch."

Allen J. Schaben | Los Angeles Times | Getty Images A view of people visiting the University of Southern California on March 12, 2019 in Los Angeles, California. Federal prosecutors say their investigation dubbed Operation Varsity Blues blows the lid off an audacious college admissions fraud scheme aimed at getting the children of the rich and powerful into elite universities.

Colleges want someone with a singular focus, not a well-rounded student, Rim said. "They want students who know what they want to do," not someone who is the president of six clubs, he added.

Private college counselor Sara Harberson touts her experience as the former associate dean of admissions at the University of Pennsylvania and the former dean of admissions at Franklin and Marshall College. She also worked as a director of college counseling at the Baldwin School in Pennsylvania.

"I teach them how to think like admissions officers. That's what parents want. They want to get the inside scoop," she said on "Power Lunch."

It's also more than just helping prep for entrance exams or filling out applications.

"If they do it right, they understand kids. They understand teenagers and really what is the very best essence of who that student is. Most students in high school, they do what everyone else does," added Harberson. Her rates go up to $600 an hour, but she said she also does free work and provides consulting at a low monthly cost.

How to find the right advisor

The first thing to figure out is if you even need one, said the IECA's Sklarow.

"If you are at a school that has a low student-to-counselor ratio, you may get all the help you need in a school setting," he explained.

Students who know they have to attend a state university or are only choosing between a couple of schools likely don't need to hire an advisor either.

The next step is to decide if you need a few hours of consultation to get headed in the right direction or if you need a full package of service, said Sklarow.

""Unless states are going to infuse and overhaul their college counseling programs at high schools, parents are going to want this. They are going to need it — all income levels." -Sara Harberson, Private college counselor

When checking out potential consultants, parents should look at the messaging on their website and pay attention to what is said in the first "get-to-know-you meeting," Sklarow said. If it is all about getting into college, that's a short-term outcome. If it is about finding the right place where the student is going to thrive, that benefit lasts a lifetime, he said.

On top of that, check out the consultant's credentials. He suggests parents look for someone who has a background in counseling and find out how many colleges the person goes to each year. Ideally, it would be someone who spends one-third of the time on the road visiting campuses.

"So much of that match is to really understand the college socially, educationally and other ways," said Sklarow.

He also said it's important to make sure the person is vetted and is a member of a national organization that has already done a background check.

Scandal aftermath

While those in the industry "held their breath" after news broke about the admissions scandal, it now looks like it ultimately is starting to improve the profession, Sklarow said.

He's seen a spike in membership at the IECA over the last few days.

"Maybe in some ways this is going to lead to an industry that looks inwardly and finds a way to even improve on what we've been doing," he said.

Rim said he's already seen an increase in interest from potential clients. "Our phones have been ringing off the hook."

He thinks part of it is that parents "didn't know how competitive this process was. Just because you have perfect scores does not mean you are going to get in."

And it is something that isn't going to change — at least for now, said Harberson.

"Unless states are going to infuse and overhaul their college counseling programs at high schools, parents are going to want this," she said. "They are going to need it — all income levels."

More from Personal Finance
This professor just had $60,000 in student debt canceled
Wealthy parents in college admissions scam may face IRS wrath
Do this one thing now to feel more confident about your financial future

CMI rises 3% on execution of export order to Mauritius

Shares of CMI rose 3.6 percent in the early trade on March 13 after the company executed its maiden export order from Mauritius.

The company in its exchange filing on BSE said that it has executed maiden export order from Mauritius for the supply of XLPE LV/HV underground power cables from the company's plant located at Baddi- Himachal Pradesh.

With the successful execution of this order, the company products are getting better recognition from other countries as well. The company is quite confident of procuring more export orders soon, it added.

Amit Jain, Chairman and Managing Director at CMI said, "We are feeling so proud to execute this prestigious order and now we are totally geared up to enter overseas in a big way."

At 0926 hours, CMI was quoting at Rs 152.80, up Rs 3.20, or 2.14 percent on the BSE.

For more market news, click here First Published on Mar 13, 2019 10:12 am

Top 5 Growth Stocks To Invest In Right Now

tags:BWLD,ISRG,TBI,MED,JWN,

Brokerages expect Ion Geophysical Corp (NYSE:IO) to announce $47.30 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Ion Geophysical’s earnings. The highest sales estimate is $48.60 million and the lowest is $46.00 million. Ion Geophysical posted sales of $46.00 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 2.8%. The business is expected to announce its next quarterly earnings results on Wednesday, August 1st.

According to Zacks, analysts expect that Ion Geophysical will report full year sales of $230.25 million for the current fiscal year, with estimates ranging from $224.80 million to $235.70 million. For the next fiscal year, analysts forecast that the business will report sales of $261.35 million per share, with estimates ranging from $255.40 million to $267.30 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Ion Geophysical.

Top 5 Growth Stocks To Invest In Right Now: Buffalo Wild Wings Inc.(BWLD)

Advisors' Opinion:

• [By Steve Symington]

  That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

• [By Peter Graham]

  A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:

Top 5 Growth Stocks To Invest In Right Now: Intuitive Surgical Inc.(ISRG)

Advisors' Opinion:

• [By Lisa Levin] Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 115 percent to $2.56. Seadrill Limited (NYSE: SDRL) gained 77 percent to $0.3935. On Tuesday, a U.S. court approved the company's plan to exit Chapter 11 bankruptcy that includes raising around $1 billion in new debt and equity through a rights offering which will be led by its biggest shareholder. DropCar, Inc. (NASDAQ: DCAR) shares climbed 21.4 percent to $2.3301 after the company issued a preliminary Q1 update on its enterprise automotive business. The company disclosed that Q1 B2B automotive volumes rose 163 percent year-over-year. Teligent, Inc. (NASDAQ: TLGT) shares jumped 19.7 percent to $3.615 following the FDA approval of Clobetasol Propionate Cream USP, 0.05%. IZEA, Inc. (NASDAQ: IZEA) surged 19.1 percent to $2.62. IZEA posted a Q4 net loss of $743,000 on sales of $6.8 million. SunPower Corporation (NASDAQ: SPWR) shares gained 15.2 percent to $9.6180. SunPower announced plans to acquire SolarWorld Americas. LexinFintech Holdings Ltd. (NASDAQ: LX) climbed 10.2 percent to $15.20. CounterPath Corporation (NASDAQ: CPAH) shares rose 8.8 percent to $3.0033. Semiconductor Manufacturing International Corporation (NYSE: SMI) gained 8.2 percent to $6.685 after falling 0.80 percent on Tuesday. Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) shares climbed 7.2 percent to $5.93. Textron Inc. (NYSE: TXT) shares rose 6.7 percent to $63.96 after the company reported stronger-than-expected earnings for its first quarter. Sibanye Gold Limited (NYSE: SBGL) gained 6.5 percent to $3.59 after dropping 4.53 percent on Tuesday. Calithera Biosciences, Inc. (NASDAQ: CALA) rose 6.3 percent to $6.75 after the company disclosed that the FDA has granted Fast Track designation to CB-839 in combination with cabozantinib for treatment of patients with advanced renal cell carcinoma. CSX Corporation (NASDAQ: CSX) gained 6.1 percent to $60.01 after reporting upbeat quarterly earnings
• [By Chris Hill]

  But there was more upbeat news elsewhere, with No. 3 airline United Continental (NYSE:UAL) beating on earnings and freight rail titan CSX (NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical (NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it's a win-win that Amazon.com (NASDAQ:AMZN) and Best Buy (NYSE:BBY) are joining forces to sell smart TVs.

• [By Keith Speights]

  If you buy stocks that have great business models and you have a long-term perspective, there's no reason to bail out even if a recession is right around the corner. As an example, let's consider Intuitive Surgical (NASDAQ:ISRG), a stock that I own. The company has a razor-and-blades type of business model with its robotic surgical systems and instruments and accessories for those systems.

• [By Stephan Byrd]

  Align Technology (NASDAQ: ALGN) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

• [By Ethan Ryder]

  Intuitive Surgical, Inc. (NASDAQ:ISRG)’s share price hit a new 52-week high during trading on Friday . The stock traded as high as $498.06 and last traded at $496.25, with a volume of 13472 shares trading hands. The stock had previously closed at $488.97.

Top 5 Growth Stocks To Invest In Right Now: TrueBlue Inc.(TBI)

Advisors' Opinion:

• [By Logan Wallace]

  ValuEngine downgraded shares of Trueblue (NYSE:TBI) from a hold rating to a sell rating in a report issued on Friday morning.

  Several other research firms have also recently weighed in on TBI. Zacks Investment Research cut shares of Trueblue from a hold rating to a sell rating in a research report on Tuesday, February 12th. BMO Capital Markets decreased their price objective on shares of Trueblue from $26.00 to $24.00 and set a market perform rating for the company in a research report on Monday, February 11th. TheStreet cut shares of Trueblue from a b- rating to a c rating in a research report on Monday, December 31st. Finally, Credit Suisse Group decreased their price objective on shares of Trueblue from $31.00 to $25.00 and set a hold rating for the company in a research report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Trueblue presently has an average rating of Hold and a consensus price target of $26.00.

• [By Max Byerly]

  Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Joseph Griffin]

  Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

• [By Motley Fool Transcribers]

  TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Top 5 Growth Stocks To Invest In Right Now: MEDIFAST INC(MED)

Advisors' Opinion:

• [By Motley Fool Transcribers]

  Medifast Inc  (NYSE:MED)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Joseph Griffin]

  MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

• [By Max Byerly]

  McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Top 5 Growth Stocks To Invest In Right Now: Nordstrom Inc.(JWN)

Advisors' Opinion:

• [By ]

  Cramer and the AAP team say today's weakness is the opportunity they have been patiently waiting for. Their target? Nordstrom (JWN) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

• [By Paul Ausick]

  One bit of good news for Walmart is that its Sam’s Club warehouse stores scored an 80 to tie for third behind Costco Wholesale Corp. (NASDAQ: COST) at 83 and Nordstrom Inc. (NYSE: JWN) at 81.

• [By Mac Greer]

  They have a lot of things in the works. They're kind of throwing some things at the wall and seeing what will stick. They have their Macy's Backstage concept, which is their discount concept. Every retailer has to have one nowadays, like a Nordstrom (NYSE:JWN) Rack, for example. They actually bought a concept store in New York City called Story, which is a store that revamps its inventory every four to eight weeks to try to keep it fresh. That would be some Inventory management job. Their buyers have their work cut out for them. But, interesting. They're trying a lot of different things. 

• [By Chris Lange]

  Nordstrom Inc. (NYSE: JWN) will reveal its fiscal fourth-quarter results later Thursday. The consensus analyst estimates are $1.42 in EPS and revenue of $4.61 billion. Shares of Nordstrom closed at $44.04 on Friday, while the consensus price target is $52.00. The 52-week range is $43.04 to $67.75.

• [By ]

  When it comes to fashion, Nordstrom (JWN) was a surprise pick, along with Macy's (M) which has been investing to fight back against Amazon.

  Boss admitted that President Trump and a trade war with China remain a wild card for retailers and that will be something they continue to watch closely.

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage gain ahead of the close was Nordstrom, Inc. (NYSE: JWN) which traded up about 13% at $59.13. The stock's 52-week range is $37.79 to $59.21. Volume was about 17 million compared to the daily average volume of 2.5 million.

Doomed Venezuela: This One Number Shows Just How Bad It Is

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-43336650&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/43336650/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Juan Guaido, president of the National Assembly who swore himself in as the leader of Venezuela. Photographer: Carlos Becerra/Bloomberg. Photo credit: &a;copy; 2019 Bloomberg Finance LP

Venezuela is in a hole, that&s;s for sure. But how deep the problem runs has been something of a mystery. That is until now.

It&s;s not just bad: It is monstrous.

&l;strong&g;A long way down at the bottom of a deep hole&l;/strong&g;

The country now owes over seven times more money to its foreign creditors, than it earns from its increasingly limited exports, new research shows.

The country&s;s external debts total $145 billion, according to the &l;a href=&q;https://www.iif.com/&q; target=&q;_blank&q;&g;Institute of International Finance&l;/a&g;&a;nbsp;(IIF) a Washington-based think tank, which just published a report on the matter. Those debts stem from direct government borrowing and as well as from loans taken out by the state-owned oil company PDVSA. There is also a small level of private sector borrowing.

Overall the combined debt (overwhelmingly&a;nbsp;from the state and PDVSA) would not be considered a huge amount of money for many developed countries, but it is to Venezuela.

The problem is that the debts dwarf the country&s;s key source of foreign currency revenue -- exports.

This year the country&s;s debts will total 7.4 times the size of the country&s;s exports, which mainly comprise oil, the IIF projections show.

In other words, for every $1 of export revenue, there are $7.40 of debts to be paid. That&s;s an increase from a ratio of $5 of debts per dollar of exports last year, IIF says.

&l;strong&g;Few choices&l;/strong&g;

Unlike the U.S. or the U.K., Venezuela cannot use its currency, the Bolivar, to pay off these debts. Venezuela is suffering a horrendous bout of hyperinflation, with the price level rising at an annualized rate of 150,097% as of March 7, 2019, according to an estimate by hyperinflation expert Steve Hanke, who is also a professor of applied economics at the Johns Hopkins University. That level of inflation makes the currency worthless, and hence investors won&s;t accept it. Instead, lenders want dollars or euros or the like.

What Venezuela relies on for much-needed foreign currency is hard currency revenue from exports. Unfortunately, not all of the export money can be used to pay the creditors. Much of it must be used to cover the costs of food, medicine, other necessities, or even maintenance spending on the PDVSA&s;s oil operations.

&q;It is safe to say that until policies change they have no money for anything,&q; says Sergi Lanau, deputy chief economist at IIF.

&l;strong&g;Possible good news ahead&l;/strong&g;

Here is a glimmer of good news. Venezuela has the largest proven oil reserves in the world, and if it can get through this crisis and implement robust market-led policies, then the economy should bounce back. Unfortunately, it could take a while to get the oil fields pumping at anything like full capacity.

&q;That is a privilege that other countries don&a;rsquo;t have,&q; says Lanau. Put bluntly, oil resources are something that most countries don&s;t have at their disposal.

On average it takes around six years for oil operations to return to their previous output following a crisis like the one Venezuela is suffering, says Lanau.

The issue at that heart of the delay in restoring the countries oil output is that oil wells and the specialized equipment needs maintaining. That hasn&s;t happened in Venezuela these past few years. Also, the country&s;s president Nicolas Maduro has taken to giving jobs in the state-owned oil company to political cronies rather than to qualified petroleum engineers.

&q;Oil industry capital expenditures are way less than depreciation and amortization,&q; says Hanke. In other words, PDVSA isn&s;t spending enough money to maintain output where it is let alone get it back to the higher levels of a few years ago.

&q;They&s;ve gutted the human capital as well,&q; he says. That&s;s led to &q;a huge safety problem which is somewhat connected to the low quality of the human capital and the low-quality infrastructure.&q;

The results have been disastrous with&a;nbsp;oil output&a;nbsp;close to halving to 1.5 million barrels a day recently from almost 3 million a day in early 2014,&a;nbsp;&l;a href=&q;https://tradingeconomics.com/venezuela/crude-oil-production&q; target=&q;_blank&q;&g;according to data from the financial information website Trading Economics&l;/a&g;.

&a;nbsp;

&a;nbsp;&l;/p&g;

What Scott Gottlieb's FDA Departure Means for Investors

Scott Gottlieb's resignation as the Food and Drug Administration's (FDA) commissioner surprised biopharma investors. Gottlieb's legacy of holding tobacco companies accountable and battling opioid manufacturers is notable, but his other achievements, including accelerating drug review times and streamlining guidance for next-generation gene therapies, were also important. The high-profile departure creates uncertainty among investors, so let's take a closer look at Gottlieb's time running the FDA and what could be next for the drug industry.

A vocal advocate

An industry insider, Gottlieb brought with him to the FDA valuable experience that he leveraged to reshape the agency's policies on opiates.

IMAGE SOURCE: GETTY IMAGES.

In an official statement on Oct. 30, 2017, he wrote, "One of my highest priorities as the Commissioner of the U.S. Food and Drug Administration is to take whatever steps we can to reduce the scope and human tragedy created by the epidemic of addiction to opioids."

It wasn't simply lip service.

Only weeks after Gottlieb's being sworn in as the FDA's 23rd commissioner, the FDA asked Endo International to stop selling Opana ER, an extended-release opiate, based upon the determination that its benefit "may no longer outweigh its risks." The drug was being manipulated to allow it to be injected, which was contributing to addiction and other health risks, including increasing the risk of spreading HIV and hepatitis C.

Gottlieb issued guidance to encourage generic-drug makers to develop alternatives to expensive, brand-name opioids that are specifically designed to limit their risk of abuse. He advocated against stigmatizing opioid addiction. Under his leadership, the agency approved a long-acting treatment for moderate to severe opioid use disorder, and it encouraged drugmakers to develop more innovate addiction treatments. He expanded the risk evaluation and mitigation strategy requirements for extended-release opioids to immediate-release opioids. He called for more training of healthcare providers on managing pain in patients. He put online sellers of illegal, unapproved, and misbranded opioids, including tramadol and oxycodone, in the crosshairs. And earlier this year, he said the FDA would begin implementing new packaging requirements that may better match the number of opioid doses to a patient's need. He also said the FDA was exploring ways to make Narcan-like products available over the counter to reduce death caused by addiction.

Opioids weren't Gottlieb's only target, though. He also took aim at tobacco companies and e-cigarette and vaping companies. For example, on March 4, he said e-cigarette use among children was at "epidemic levels." He targeted companies using kid-friendly marketing and flavors for their bad behavior, cracked down on stores for selling to minors, and instituted new studies to evaluate risks.

Gottlieb was also a big supporter of innovation. During his time at the FDA, it developed new regulatory frameworks for technology-specific and disease-specific innovations. He oversaw the approvals of the first gene therapies for cancer and blindness and an approval of a comprehensive genetic screening test for cancer patients. The first cancer drugs addressing the genetic makeup of the cancer, rather than its location, were also given the green light.

He advocated to support follow-on innovations that could boost competition to help crimp costs. The agency approved the first biosimilars -- lower-cost alternatives to high-priced specialty drugs -- on his watch too. Overall, his goal to speed the FDA's review of drugs contributed to the approval of 46 new therapies in 2017 and 59 new drugs in 2018, a record high. He also laid groundwork for new trial designs that could foster even faster drug development and approvals in the future.

IMAGE SOURCE: GETTY IMAGES.

Now what

Gottlieb's success in holding drug companies accountable, while also spearheading innovation, was refreshing. Will his successor be as vocal a critic of opioid drugmakers and tobacco companies? Will they be as comfortable changing the FDA's long-standing practices and processes? Or will the FDA take a slower, more traditional approach from here on out? Until a new commissioner is named, biopharma and medtech stocks will probably become more volatile as stakeholders debate the pros and cons of potential replacements. That volatility could create buying opportunities, especially in companies working on next-generation treatments, but that will depend on how much the next FDA commissioner shares Gottlieb's vision. Therefore, investors should expect uncertainty until a new person's in charge of the FDA.

Head-To-Head Analysis: ArcelorMittal (MT) & China Precision Steel (CPSL)

ArcelorMittal (NYSE:MT) and China Precision Steel (OTCMKTS:CPSL) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

Insider and Institutional Ownership

Get ArcelorMittal alerts:

3.0% of ArcelorMittal shares are owned by institutional investors. 0.1% of ArcelorMittal shares are owned by company insiders. Comparatively, 0.4% of China Precision Steel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Dividends

ArcelorMittal pays an annual dividend of $0.09 per share and has a dividend yield of 0.4%. China Precision Steel does not pay a dividend. ArcelorMittal pays out 1.6% of its earnings in the form of a dividend.

Earnings and Valuation

This table compares ArcelorMittal and China Precision Steel’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ArcelorMittal	$76.03 billion	0.28	$5.15 billion	$5.76	3.63
China Precision Steel	N/A	N/A	N/A	N/A	N/A

ArcelorMittal has higher revenue and earnings than China Precision Steel.

Analyst Ratings

This is a summary of current ratings and recommmendations for ArcelorMittal and China Precision Steel, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ArcelorMittal	0	3	5	0	2.63
China Precision Steel	0	0	0	0	N/A

ArcelorMittal presently has a consensus price target of $38.00, indicating a potential upside of 81.73%.

Profitability

This table compares ArcelorMittal and China Precision Steel’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ArcelorMittal	6.77%	13.24%	6.42%
China Precision Steel	N/A	N/A	N/A

Summary

ArcelorMittal beats China Precision Steel on 7 of the 9 factors compared between the two stocks.

About ArcelorMittal

ArcelorMittal, together with its subsidiaries, owns and operates steel manufacturing and mining facilities in Europe, North and South America, Asia, and Africa. It operates through NAFTA, Brazil, Europe, ACIS, and Mining segments. The company produces finished and semi-finished steel products with various specifications. Its principal steel products include semi-finished flat products, such as slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, and tinplate and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products, including bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company's principal mining products comprise iron ore lump, fines, concentrate, pellets, and sinter feed; and coking, pulverized coal injection, and thermal coal. It provides its steel products to the automotive, appliance, engineering, construction, energy, and machinery industries. The company sells its products in local markets and through a centralized marketing organization to customers in approximately 160 countries. It has iron ore mining activities in Brazil, Bosnia, Canada, Kazakhstan, Liberia, Mexico, Ukraine, and the United States; and coal mining activities in Kazakhstan and the United States. The company was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.

About China Precision Steel

China Precision Steel, Inc., a steel processing company, manufactures and sells cold-rolled precision steel products. It produces and sells precision cold-rolled steel products ranging from 7.5 mm to 0.03 mm. The company's steel products comprise cold-rolled and hard-rolled low carbon steel products for steel roofing, food packaging, dry batteries, electronic devices, and kitchen tools; cold-rolled and hard-rolled high carbon steel products for automobile parts and components, grinding pieces, saw blades, and weaving needles; and tailor made cold rolled steel products. It also provides heat treatment, and cutting and slitting services for medium and high-carbon hot-rolled steel strips not exceeding 7.5 mm thickness. The company sells its products to component manufacturers and directly to the end-users in the People's Republic of China, Indonesia, Thailand, the Caribbean, Nigeria, Ethiopia, and Turkey. China Precision Steel, Inc. is headquartered in Sheung Wan, Hong Kong.

This Latest Memory Industry News Isn't Good for Micron

Micron Technology (NASDAQ:MU), like its peers, has to cope with the reality that computer memory prices -- after having been elevated for quite a while -- are now on the decline. Unfortunately for Micron, it would appear that contract prices for DRAM -- the memory product that makes up the bulk of the company's revenue and an even bigger share of its gross profit -- are declining at an even faster pace than expected. 

Let's take a closer look at what's going on.

Image source: Micron.

A 30%-off sale

According to market researchers with TrendForce, contract prices for PC DRAM were expected to decline 25% sequentially in the current quarter but the actual drop was "nearly 30%." 

That, the researchers say, represents "the sharpest decline in a single season since 2011." 

According to Micron's analyst day presentation last year, 26% of the company's DRAM revenue in the first half of its fiscal year 2018 was PC DRAM. The remaining revenue was split between servers, mobile devices, and specialty applications, like networking and computer graphics. 

TrendForce also says that because the industrywide shortage of low-end PC CPUs is expected to persist through the third quarter of 2019, PC makers "are unable to carry out the consumption of DRAM chips under demand suppression." (Micron management did indicate that the company's business was being impacted by these CPU shortages during its December 2018 earnings call.)

It's not just PCs, though

Although TrendForce's report focused specifically on PC DRAM contract prices, the DRAM demand decline is by no means limited to this segment. During Micron's most recent earnings call, CEO Sanjay Mehrotra claimed that there are inventory corrections going on in other segments, including enterprise and cloud servers, as well as the industrial market. 

According to the executive, "This inventory adjustment period will contribute to weaker demand conditions in DRAM that will likely persist through the first half of calendar 2019." 

Mehrotra also explained that DRAM demand is being impacted by slackening smartphone unit shipments "particularly at the high end."

The comment about the high end is important because higher-end smartphones tend to have more DRAM content than lower-end smartphones, potentially exacerbating the impact on memory makers' businesses. To illustrate, a midrange smartphone like the Moto G7 has 4 GB of DRAM, while a flagship smartphone like the Huawei P20 Pro comes in configurations of 6 GB to 8 GB of DRAM -- up to twice the memory that a midrange device has. Lower-end smartphones can have even less than 4 GB.

Investor takeaway

The memory market is cyclical. Sometimes DRAM prices and profitability surge, and following those surges, there are often violent corrections. Indeed, although Micron generated $11.95 in earnings per share (EPS) in its fiscal 2018, analysts are only expecting the company's EPS to drop to $7.50 in fiscal 2019 followed by a further decline to $6.34 in the subsequent year. 

Those projected EPS declines aren't a result of poor execution on Micron's part -- in fact, Micron's technology position in DRAM seems to be improving -- but are instead the product of the reality that memory prices are on the decline and, with them, memory makers' gross and net profit margins.

TrendForce's report that PC DRAM prices dropped more than expected during the quarter isn't a thesis changer -- investors have already braced themselves for large DRAM declines -- but it's discouraging news nonetheless. The sooner that DRAM prices find a bottom, the better it'll be for Micron and other memory manufacturers.

AtriCure Inc (ATRC) Files 10-K for the Fiscal Year Ended on December 31, 2018

AtriCure Inc (NASDAQ:ATRC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices. AtriCure Inc has a market cap of $1.19 billion; its shares were traded at around $30.77 with and P/S ratio of 5.23.

For the last quarter AtriCure Inc reported a revenue of $49.9 million, compared with the revenue of $42.15 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $201.6 million, an increase of 15.4% from last year. For the last five years AtriCure Inc had an average revenue growth rate of 19.2% a year.

The reported loss per diluted share was 62 cents for the year, compared with the loss per share of $0.61 in the previous year. The AtriCure Inc had an operating margin of -8.49%, compared with the operating margin of -14.3% a year before. The 10-year historical median operating margin of AtriCure Inc is -14.77%. The profitability rank of the company is 5 (out of 10).

At the current stock price of $30.77, AtriCure Inc is traded at 66.6% premium to its historical median P/S valuation band of $18.47. The P/S ratio of the stock is 5.23, while the historical median P/S ratio is 3.14. The stock gained 73.74% during the past 12 months.

For the complete 20-year historical financial data of ATRC, click here.

Best Heal Care Stocks To Buy Right Now

tags:ATVI,LGF.A,HSEA,MEI,DOV,ERJ,

There was once a time when mid-level bands with a modest following could make a pretty decent living playing music. They’d put out a record, sell a couple hundred thousand copies and then go on tour to promote it – which would drive additional sales, even as the tour itself was lucky to break even.

For the largest acts, this formula was a bona fide moneymaking bonanza, lining the pockets of all involved, including the musicians, managers, promoters and record labels. For everyone else, it didn’t produce vast riches but nonetheless supported careers and promoted the creation of new music.

Times, however, have changed. Besides a handful of superstars, it’s impossible for bands and musicians to generate significant revenue taking this approach. And the reason is simple: Consumers won’t pay much for music.

Napster jump-started this trend back in the 90s, pirating content and making it available online, producing a generation of listeners who didn't value music because they were able to download it for free. Then, streaming services basically continued the practice.

Best Heal Care Stocks To Buy Right Now: Activision Blizzard, Inc(ATVI)

Advisors' Opinion:

• [By Keith Noonan, Travis Hoium, and Dan Caplinger]

  With an eye toward the ultralong term, we asked three Motley Fool investors to identify a company with qualities that could pave the way to ongoing growth and stellar returns. Here's why they think that Appian (NASDAQ:APPN), The Walt Disney Company (NYSE:DIS), and Activision Blizzard (NASDAQ:ATVI) are stocks that will flourish over the next half-century.

• [By Chris Lange]

  Activision Blizzard Inc. (NASDAQ: ATVI) released its most recent quarterly report after the markets closed on Tuesday. Of all the video game stocks, it seems that Activision is the only one to come out ahead after earnings. While Fortnite took its toll on all the major consoles, Activision is playing the long game.

• [By Keith Noonan]

  With that in mind, here's why Activision Blizzard (NASDAQ:ATVI), Walt Disney (NYSE:DIS), and Apple (NASDAQ:AAPL) are stocks that you should consider adding to your portfolio.

• [By Chris Lange]

  Activision Blizzard Inc. (NASDAQ: ATVI) is scheduled to release its fourth-quarter financial results after the markets close on Tuesday. Thomson Reuters consensus estimates are calling for $1.28 in earnings per share (EPS) and $3.04 billion in revenue. In the same period of last year, the video game maker had $0.94 in EPS and $2.64 billion in revenue.

Best Heal Care Stocks To Buy Right Now: (LGF.A)

Advisors' Opinion:

• [By Stephan Byrd]

  World Wrestling Entertainment (NYSE: WWE) and Lions Gate Entertainment Corp. Class A (NYSE:LGF.A) are both mid-cap consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Lions Gate Entertainment Corp. Class A (LGF.A)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  ValuEngine upgraded shares of Lions Gate Entertainment Corp. Class A (NYSE:LGF.A) from a strong sell rating to a sell rating in a research note published on Thursday morning.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Lionsgate (LGF.A)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Lions Gate Entertainment (NYSE:LGF.A) was upgraded by equities research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Best Heal Care Stocks To Buy Right Now: HSBC Holdings plc(HSEA)

Advisors' Opinion:

• [By Lisa Levin] Gainers Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares rose 29.5 percent to $2.15 in pre-market trading after reporting pre-clinical data demonstrating potential of Prexigebersen presented at the annual American Association for Cancer Research meeting in Chicago. Sientra, Inc. (NASDAQ: SIEN) rose 16.7 percent to $12.90 in pre-market trading following the announcement of FDA approval for PMA supplement. Aqua Metals, Inc. (NASDAQ: AQMS) rose 13.5 percent to $2.95 in pre-market trading after climbing 14.04 percent on Wednesday. Harmony Gold Mining Company Limited (NYSE: HMY) rose 5.6 percent to $2.09 in pre-market trading. Alcoa Corporation (NYSE: AA) shares rose 5 percent to $62.32 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its FY18 adjusted EBITDA outlook. Gold Fields Limited (ADR) (NYSE: GFI) shares rose 4.9 percent to $4.11 in pre-market trading after gaining 1.03 percent on Wednesday. ABB Ltd (NYSE: ABB) shares rose 4.3 percent to $24.47 in pre-market trading after reporting Q1 results. WPP plc (NYSE: WPP) rose 4.2 percent to $82.99 in pre-market trading. American Express Company (NYSE: AXP) rose 4 percent to $98.95 in pre-market trading after the company reported stronger-than-expected profit for its first quarter. HSBC Holdings plc (NYSE: HSEA) rose 3.4 percent to $27.30 in pre-market trading. Shire plc (NASDAQ: SHPG) rose 3.4 percent to $167.95 in pre-market trading. Takada offered to buy Shire at £46.50 per share, Reuters reported. Vipshop Holdings Limited (NYSE: VIPS) rose 3.1 percent to $16.43 in pre-market trading. iRobot Corporation (NASDAQ: IRBT) shares rose 3 percent to $63.66 in the pre-market trading session.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Fluor Corporation (NYSE: FLR) fell 13.4 percent to $51.10 in pre-market trading after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year. Integrated Media Technology Limited (NASDAQ: IMTE) fell 9.8 percent to $28.97 in pre-market trading after surging 46.29 percent on Thursday. Gogo Inc. (NASDAQ: GOGO) shares fell 8.2 percent to $8.81 in pre-market trading after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow. Sharing Economy International Inc. (NASDAQ: SEII) shares fell 7.5 percent to $3.98 in pre-market trading after climbing 22.16 percent on Thursday. Arista Networks, Inc. (NYSE: ANET) fell 7.4 percent to $248.00 in pre-market trading following first-quarter earnings. Web.com Group, Inc. (NASDAQ: WEB) fell 6.7 percent to $18.00 in pre-market trading after reporting Q1 results. Varex Imaging Corporation (NASDAQ: VREX) fell 5.2 percent to $34 in pre-market trading after reporting Q2 results. Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 5.2 percent to $7.60 in pre-market trading after dropping 3.02 percent on Thursday. AMN Healthcare Services, Inc (NYSE: AMN) shares fell 4.7 percent to $61.70 in pre-market trading following Q1 earnings. HSBC Holdings plc (NYSE: HSEA) fell 4.6 percent to $25.15 in pre-market trading after reporting Q1 results. Stratasys Ltd. (NASDAQ: SSYS) shares fell 4 percent to $16.66 in pre-market trading after dropping 2.86 percent on Thursday. Melco Resorts & Entertainment Limited (NASDAQ: MLCO) fell 4 percent to $30.65 in pre-market trading. Century Aluminum Co (NASDAQ: CENX) fell 4 percent to $15.76 in pre-market trading following Q1 results. HSBC Holdings plc (NYSE: HSBC) shares fell 3.5 percent to $48.10 in pre-market tr

Best Heal Care Stocks To Buy Right Now: Methode Electronics, Inc.(MEI)

Advisors' Opinion:

• [By Logan Wallace]

  Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

  Get Methode Electronics alerts: Analysts Expect Methode Electronics (MEI) Will Announce Quarterly Sales of $242.88 Million (americanbankingnews.com) Methode Electronics (MEI) Receives Consensus Recommendation of “Hold” from Brokerages (americanbankingnews.com) Analysts Anticipate Methode Electronics (MEI) Will Post Earnings of $0.74 Per Share (americanbankingnews.com) Commit To Buy Methode Electronics At $35, Earn 5.8% Annualized Using Options (nasdaq.com)

  Shares of Methode Electronics opened at $41.75 on Tuesday, Marketbeat reports. Methode Electronics has a 12-month low of $41.85 and a 12-month high of $42.60. The company has a market capitalization of $1.56 billion, a P/E ratio of 16.37, a price-to-earnings-growth ratio of 0.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.03 and a quick ratio of 3.47.

• [By Logan Wallace]

  ValuEngine cut shares of Methode Electronics (NYSE:MEI) from a hold rating to a sell rating in a research note published on Wednesday morning.

  MEI has been the topic of several other research reports. Zacks Investment Research lowered Methode Electronics from a buy rating to a hold rating in a research report on Saturday, February 24th. Robert W. Baird reissued an outperform rating and set a $51.00 target price (up previously from $48.00) on shares of Methode Electronics in a research report on Friday, March 2nd. Finally, TheStreet lowered Methode Electronics from a b rating to a c+ rating in a research report on Friday, March 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $48.75.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Methode Electronics (MEI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Buy Right Now: Dover Corporation(DOV)

Advisors' Opinion:

• [By Max Byerly]

  Dover (NYSE: DOV) and Apergy (NYSE:APY) are both industrial products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

• [By Lee Samaha]

  The case for buying stock in Dover Corporation (NYSE:DOV) seems to be a strong one at first glance. After all, Dover doesn't own the sexiest set of businesses out there, and its expected 3% to 4% organic revenue growth rate isn't the most compelling growth story of 2018. Moreover, the company has a recent history of operational mishaps. It gets worse: Management recently admitted overestimating end demand in one of its three segments in 2018 (refrigeration & food equipment) and candidly talked of the need to execute better on margin conversion.

• [By Max Byerly]

  Shares of Dover Corp (NYSE:DOV) have received an average rating of “Hold” from the sixteen analysts that are covering the company, MarketBeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $89.27.

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Dover Corp. (NYSE: DOV) which traded down about 18% at $76.68. The stock's 52-week range is $75.88 to $109.06. Volume was 3.7 million compared to the daily average volume of 1.6 million.

Best Heal Care Stocks To Buy Right Now: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors' Opinion:

• [By Adam Levine-Weinberg]

  Last December, shares of Embraer (NYSE:ERJ) spiked following reports that it might sell itself to aerospace giant Boeing (NYSE:BA). Since then, the Brazilian government has ruled out a full takeover of Embraer but signaled its interest in facilitating a partnership between the two companies in the commercial aviation business.

• [By Joseph Griffin]

  Hanson & Doremus Investment Management lessened its holdings in Embraer SA (NYSE:ERJ) by 3.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,898 shares of the aerospace company’s stock after selling 2,603 shares during the quarter. Hanson & Doremus Investment Management’s holdings in Embraer were worth $1,591,000 at the end of the most recent quarter.

• [By Paul Ausick]

  Boeing also confirmed on Thursday that it has discussed a “possible combination” with Brazil’s Embraer S.A. (NYSE: ERJ), a response to the deal Bombardier struck with Airbus in which the European company took control of Bombardier’s C Series program. A deal between Boeing and Embraer is no sure thing, mainly because the Brazilian government holds a controlling interest in Embraer.

Should Tesla be nervous? Rival unveils new EV

 

Polestar 2 is a premium five-door fastback with two electric motors and a 78 kWh battery capacity2 that will enable a targeted range of 500 km3, based on Volvo Car Group's adaptable Compact Modular Architecture platform (CMA). The 27-module battery pack is integrated into the floor and contributes to the rigidity of the chassis as well as improves the car's noise, vibration and harshness (NVH) levels – road noise has been reduced by 3.7 dB compared to a traditional chassis. (Photo: Stefan Isaksson, Polestar)

Tesla is facing another potential rival in the electric vehicle market.

Polestar, Volvo's standalone electric vehicle brand, is unveiling its Polestar 2 model, a five-door car  that will contain two electric motors. According to the company, the car is targeted to travel up to 275 miles on a single charge with its 78kWh battery. With about 408 horsepower, the vehicle can go from 0 to 60 mph in less than five seconds.

The launch edition of the Polestar 2 will cost $63,000 before $7,500 in federal incentives. Production of the car will begin in China in early 2020, and prospective customers can pre-order online at polestar.com.

Polestar said its car is meant to compete with Tesla's Model 3. Earlier this week, Tesla announced a $35,000 version of its EV.  Previously, the Model 3 had a starting price of about $44,000. Tesla's pricier models, the Model S and Model X, have starting prices of $94,000 and $97,000, respectively.

FacebookTwitterGoogle+LinkedInVolvo's new Polestar 2 electric car FullscreenPost to FacebookPosted!

A link has been posted to your Facebook feed.

Polestar, Volvo's standalone electric vehicle brand, is unveiling its Polestar 2 model, a five-door car that will contain two electric motors. According to the company, the car is targeted to travel up to 275 miles on a single charge with its 78kWh battery. With about 408 horsepower, the vehicle can go from 0 to 60 mph in less than five seconds. Stefan Isaksson, PolestarFullscreenThe launch edition of the Polestar 2 will cost $63,000 before $7,500 in federal incentives. Production of the car will begin in China in early 2020, and prospective customers can pre-order online at polestar.com. Stefan Isaksson, PolestarFullscreenPolestar said its car is meant to compete with Tesla's Model 3. Earlier this week, Tesla announced a $35,000 version of its EV. Previously, the Model 3 had a starting price of about $44,000. Tesla's pricier models, the Model S and Model X, have starting prices of $94,000 and $97,000, respectively. Stefan Isaksson, PolestarFullscreenEverything about the vehicle "has been designed and engineered with passion and dedication," Polestar CEO Thomas Ingenlath said in a statement. "As an electric performance brand, and through the forthcoming launch of a portfolio of fully electric cars, Polestar is determined to address the world's air quality challenges." Stefan Isaksson, PolestarFullscreen"Polestar 2 is our first fully electric car and first volume model. Everything about it has been designed and engineered with passion and dedication. As an electric performance brand, and through the forthcoming launch of a portfolio of fully electric cars, Polestar is determined to address the world's air quality challenges. Polestar delivers electric performance cars that are great to own and drive," says Thomas Ingenlath, Chief Executive Officer of Polestar. Stefan Isaksson, PolestarFullscreenPolestar 2 is a premium five-door fastback with two electric motors and a 78 kWh battery capacity2 that will enable a targeted range of 500 km3, based on Volvo Car Group's adaptable Compact Modular Architecture platform (CMA). The 27-module battery pack is integrated into the floor and contributes to the rigidity of the chassis as well as improves the car's noise, vibration and harshness (NVH) levels – road noise has been reduced by 3.7 dB compared to a traditional chassis. Stefan Isaksson, PolestarFullscreenPolestar will answer the important question of charging Polestar 2 with a smart, convenient and extensive approach. With a connected digital solution available both in-car and on mobile devices, Polestar is setting up strategic collaborations to give Polestar 2 owners easy and hassle-free access to the world's largest public charging networks. PolestarFullscreenFor Polestar, performance underlies the entire driving experience. The all-wheel drive electric powertrain in Polestar 2 produces 300 kW (408 hp) and 660 Nm (487 lb-ft). This translates to a 0-100 km/h acceleration time of less than 5 seconds. PolestarFullscreenThe standard dynamic chassis can be enhanced by the Performance Pack that improves driving dynamics with Öhlins dampers, Brembo brakes and unique 20-inch forged wheels. Polestar's signature gold seat belts, brake callipers and valve caps complete the performance visuals. PolestarFullscreenHighlighting the technology spearhead role that Polestar plays within the Volvo Car Group, Polestar 2 is one of the first cars in the world to embed an infotainment system powered by Android. The Android backbone provides a solid and adaptable digital environment for apps and vehicle functions to coexist, and brings embedded Google services to a car for the first time – including the Google Assistant, Google Maps with support for electric vehicles and the Google Play Store5. Natural voice control and a new 11-inch touch screen display bring the new interface to life. PolestarFullscreenPhone-as-Key technology enables car sharing and a more integrated ownership experience, as well as Polestar's connected services such as pick-up and delivery. It also allows Polestar 2 to sense the driver upon approach. Smart features like enlarged graphics in the instrument cluster allow the driver to easily see the charging status and range before entering the car. Polestar 2 can also predetermine the driver's next move to create a seamless experience with a prepared cabin and quick start sequence. PolestarFullscreenInterested in this topic? You may also want to view these photo galleries:Replay1 of 112 of 113 of 114 of 115 of 116 of 117 of 118 of 119 of 1110 of 1111 of 11AutoplayShow ThumbnailsShow CaptionsLast SlideNext Slide

Everything about the vehicle "has been designed and engineered with passion and dedication," Polestar CEO Thomas Ingenlath said in a statement. "As an electric performance brand, and through the forthcoming launch of a portfolio of fully electric cars, Polestar is determined to address the world's air quality challenges."

Competitor move: Tesla announces long-promised $35,000 Model 3

Highest-rated vehicles: These are the 10 best cars, SUVs and pickups of 2019, according to Consumer Reports

The EV will also have an infotainment system powered by Android. With this installation, Google services — such as Google Assistant and Google Maps — will be embedded into the car. Moreover, the car will use phone-as-key technology.

FacebookTwitterGoogle+LinkedInVolvo Polestar FullscreenPost to FacebookPosted!

A link has been posted to your Facebook feed.

Volvo spokesman Duncan Forrester launches the overhauled Polestar brand at the Yuz Museum in Shanghai. Andreas Hillergren, PolestarFullscreenVolvo's Polestar 1 plug-in hybrid performance car. Petter BorgFullscreenVolvo's Polestar 1 plug-in hybrid performance car. Petter BorgFullscreenVolvo's Polestar 1 plug-in hybrid performance car. Petter BorgFullscreenThe interior of Volvo's Polestar 1 plug-in hybrid performance car. PolestarFullscreenVolvo's Polestar 1 plug-in hybrid performance car. Stefan IsakssonFullscreenVolvo's Polestar 1 plug-in hybrid performance car. Stefan IsakssonFullscreenVolvo's Polestar 1 plug-in hybrid performance car. Petter BorgFullscreenVolvo's Polestar 1 plug-in hybrid performance car. PolestarFullscreenInterested in this topic? You may also want to view these photo galleries:Replay1 of 92 of 93 of 94 of 95 of 96 of 97 of 98 of 99 of 9AutoplayShow ThumbnailsShow CaptionsLast SlideNext Slide

Follow USA TODAY intern Ben Tobin on Twitter: @TobinBen